Dynamic O-(2-[ 18F]fluoroethyl)-L-tyrosine (F-18 FET) PET for glioma grading: Assessment of individual probability of malignancy

Clinical Nuclear Medicine

Volumn 36, Issue 10, 2011, Pages 841-847

  Calcagni, Maria Lucia ^a   Galli, Guido ^a   Giordano, Alessandro ^a   Taralli, Silvia ^a   Anile, Carmelo ^a   Niesen, Andreas ^b   Baum, Richard Paul ^b  

^a CATHOLIC UNIVERSITY   (Italy)

^b Center for PET   (Germany)

Author keywords

Dynamic F 18 FET PET; Grading of gliomas; Logistic regression

Indexed keywords

O (2 FLUOROETHYL)TYROSINE F 18; RADIOPHARMACEUTICAL AGENT; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BRAIN TUMOR; CANCER GRADING; CANCER RECURRENCE; CLINICAL ARTICLE; DIAGNOSTIC ACCURACY; DISEASE COURSE; DISEASE SEVERITY; FEMALE; GLIOMA; HUMAN; MALE; POSITRON EMISSION TOMOGRAPHY; SENSITIVITY AND SENSIBILITY;

ADOLESCENT; ADULT; AGED; BRAIN NEOPLASMS; FEMALE; GLIOMA; HUMANS; MALE; MIDDLE AGED; NEOPLASM GRADING; POSITRON-EMISSION TOMOGRAPHY; TIME FACTORS; TYROSINE; YOUNG ADULT;

EID: 80053614004     PISSN: 03639762     EISSN: 15360229     Source Type: Journal    
DOI: 10.1097/RLU.0b013e3182291b40     Document Type: Article

References (13)

1. 18F]fluoroethyl)-L-tyrosine for tumor imaging. J Nucl Med. 1999;40: 205-212. (Pubitemid 29044193)
2. 11C]methionine uptake in brain tumours: initial results of a comparative study. Eur J Nucl Med. 2000;27:542-549. (Pubitemid 30262620)
3. 18F]fluoroethyl)-L-tyrosine PET for the diagnosis of recurrent glioma. Eur J Nucl Med Mol Imaging. 2004;31:1464-1470. (Pubitemid 39592765)
4. 18F]fluoroethyl)-L-tyrosine versus magnetic resonance imaging in the diagnosis of recurrent gliomas. Neurosurgery. 2005;57:505-511. (Pubitemid 41254459)
5. 18F]fluoroethyl)-L-tyrosine PET for monitoring the effects of intracavitary radioimmunotherapy in patients with malignant glioma. Eur J Nucl Med Mol Imaging. 2006;33: 792-800. (Pubitemid 43979687)
6. 18F]fluoroethyl)-L-tyrosine (FET) PET in the diagnosis of a glioma recurrence after multimodal treatment. J Neurooncol. 2008;88:27-35.
7. 18F] fluoroethyl)-L-tyrosine: uptake mechanisms and clinical applications. Nucl Med Biol. 2006;33:287-294.
8. 18F] fluoroethyl)-L-tyrosine PET in the clinical evaluation of primary brain tumours. Eur J Nucl Med Mol Imaging. 2005;32:422-429. (Pubitemid 40591174)
9. 18F-FET PET for grading of recurrent gliomas: is evaluation of uptake kinetics superior to standard methods? J Nucl Med. 2006;47:393-403. (Pubitemid 46768480)
10. Pöpperl G, Kreth FW, Mehrkens JH, et al. FET PET for the evaluation of untreated gliomas: correlation of FET uptake and uptake kinetics with tumour grading. Eur J Nucl Med Mol Imaging. 2007;34:1933-1942. (Pubitemid 350212135)
11. 18F]fluoroethyl)-L-tyrosine. Appl Radiat Isot. 2002;57:853-856. (Pubitemid 35284220)
12. 18F]Fluoroethyl)-L-tyrosine in vitro and in vivo. J Nucl Med. 1999;40:1367-1373. (Pubitemid 29385647)
13. Pichler R, Dunzinger A, Wurm G, et al. Is there a place for FET PET in the initial evaluation of brain lesions with unknown significance? Eur J Nucl Med Mol Imaging. 2010;37:1521-1528.